ProVate Gets FDA Approval to Treat Pelvic Organ Prolapse - MPR

The FDA has approved ProVate (ConTIPI) for the temporary, nonsurgical management of pelvic organ prolapse in women.

Indegene, ConTIPI Medical partner to launch ProVate, a device to treat pelvic organ prolapse in women - Express Pharma

POP Medical given FDA nod on pelvic device - Globes

Obliterative procedures for pelvic organ prolapse

Contipi – Solutions

Pelvic Organ Prolapse — THE PELVIC MEDICINE CENTRE

Screening and Prophylaxis (Section G) - Context, Principles and Practice of TransGynecology

Text - Pelvic Organ Prolapse: Nonsurgical Treatment

Pelvic organ prolapse: New answers to a problem plaguing 50% of women - ISRAEL21c

ConTIPI Medical Has Received FDA Approval for the Marketing of a Unique Product for the Treatment of Pelvic Organ Prolapse in Women

Indegene expands partnership with ConTIPI Medical Ltd to manage pelvic organ prolapse in women worldwide, News